Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t
-
ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law
-
Totaligent (OTCID: TGNT) forms JV with GloMed Solutions, a Japanese company with a proven distribution network in the Asia-Pacific region.
-
The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
-
Did ADMA Biologics Mislead Investors about Alleged Channel Stuffing? BFA Law Notifies Investors with Losses of the Pending Securities Fraud Investigation
-
The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
-
Valable pour la période 2025–2027, cet agrément permet aux entreprises innovantes françaises de faire appel à l’expertise d’Intravacc dans le développement de vaccins, le développement analytique et...
-
Die Zulassung für den Zeitraum 2025–2027 ermöglicht französischen Innovatoren den Zugang zu den Dienstleistungen von Intravacc in den Bereichen Impfstoffentwicklung, analytische Entwicklung und...
-
ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation
-
ADMA Biologics Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money